Nanosphere's Q2 Revenue Falls, Loss Widens | GenomeWeb
NEW YORK (GenomeWeb News) – Nanosphere today reported that its second-quarter revenues fell 62 percent and its loss grew by 17 percent. 
 
For the quarter ended June 30, 2008, Nanogen’s total revenue fell to $195,000 from $510,000 in the second quarter of 2007.
 
Revenue from grants and contracts fell to zero for the quarter, compared to $503,245 in the prior-year quarter, while product sales grew to $194,715 from $7,025 in the second quarter of 2007.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.